Article
Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Feb 1998
Kensler T W, He X, Otieno M, Egner P A, Jacobson L P, Chen B, Wang J S, Zhu Y R, Zhang B C, Wang J B, Wu Y, Zhang Q N, Qian G S, Kuang S Y, Fang X, Li Y F, Yu L Y, Prochaska H J, Davidson N E, Gordon G B, Gorman M B, Zarba A, Enger C, Muñoz A, Helzlsouer K J
Abstract excerpt
In 1995, 234 adults from Qidong, People's Republic of China, were enrolled and followed in a Phase IIa 4-methyl-5-(N-2-pyrazinyl)-1,2-dithiole-3-thione (oltipraz) chemoprevention trial. Residents of this area are at high risk for development of hepatocellular carcinoma, in part due to consumption...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.